Teradyne (TER) Tops Q4 EPS by 4c, Beats on Revenue; Offers Q1 Guidance

Teradyne (NASDAQ: TER) reported Q4 EPS of $0.95, $0.04 better than the analyst estimate of $0.91. Revenue for the quarter came in at $753 million versus the consensus estimate of $740.47 million.

GUIDANCE:

Teradyne sees Q1 2025 EPS of $0.58-$0.68, versus the consensus of $0.62. Teradyne sees Q1 2025 revenue of $660-700 million, versus the consensus of $692 million.

For earnings history and earnings-related data on Teradyne (TER) click here.

You May Also Be Interested In

• S&P Dow Jones Indices adds Bloom Energy to S&P 500 index
• ADARx Pharmaceuticals files for proposed IPO
• Starlo to acquire Mexico silver project in reverse takeover deal